New data have shown for the first time that a combination of targeted therapies can improve survival in patients with advanced bowel cancer. Results of the BEACON CRC Phase III trial have shown that triple therapy targeting BRAF mutations in progressive metastatic colorectal tumors significantly improved overall survival and objective response compared to standard care.
"Patients who were seen in an emergency department that was not associated with where they received cancer treatment or one of the 14 major cancer centers in Ontario Province of Canada were less likely to be admitted to hospital but more likely to die within 30 days of the visit," said Dr. Keerat Grewal, an emergency physician at Mount Sinai Hospital, and the University of Toronto.
Physicians will be able to predict which of their patients with severe asthma are likely to benefit from treatment with systemic corticosteroids — and which might only suffer their side effects — with help from a dozen clinical variables researchers have identified using machine learning techniques.
Patients with type 2 diabetes should be prescribed physical activity to control blood sugar and improve heart health. That is one of the recommendations in a position paper of the European Association of Preventive Cardiology (EAPC), a branch of the European Society of Cardiology (ESC). The paper is published in the European Journal of Preventive Cardiology.